Skip to content
10-Q/A

Quarterly Report

Sanomedics, Inc.

0001477932-15-002649

← back to feed
Filed
Apr 21, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 11, 2014 113.67M sh
Stockholders Equity Q3 2014 · Dec 31, 2013 −$5.12M
Current Liabilities Q3 2014 · Dec 31, 2013 $3.36M
Total Liabilities Q3 2014 · Dec 31, 2013 $5.23M
Current Assets Q3 2014 · Dec 31, 2013 $68.46K
Total Assets Q3 2014 · Dec 31, 2013 $105.83K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $93.31K
Cash And Equivalents Q3 2014 · Dec 31, 2012 $26.08K
Sga Expense restated Q3 2014 · Sep 30, 2013 $299.68K
Sga Expense restated Q3 2014 · Sep 30, 2013 $753.49K
Rd Expense Q3 2014 · Sep 30, 2013 $24.25K
Rd Expense Q3 2014 · Sep 30, 2013 $77.75K
Net Income restated Q3 2014 · Sep 30, 2013 $59.76K
Net Income restated Q3 2014 · Sep 30, 2013 −$2.51M
Operating Income restated Q3 2014 · Sep 30, 2013 −$340.35K
Operating Income restated Q3 2014 · Sep 30, 2013 −$1.02M
Gross Profit restated Q3 2014 · Sep 30, 2013 $78.47K
Gross Profit restated Q3 2014 · Sep 30, 2013 $165.96K
Cost Of Revenue restated Q3 2014 · Sep 30, 2013 $12.2K
Cost Of Revenue restated Q3 2014 · Sep 30, 2013 $45.79K